Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Kashem

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Science of the Total Environment|February 25, 2023
Microalgal bioremediation of brackish aquaculture wastewaterAbdurahman Hafez Mohammed Kashem, Probir Das, Mohammad AbdulQuadir, et al.
Annals of Thoracic Surgery Short Reports|March 18, 2025
The Ross Procedure in Active Infective Endocarditis: A Comparison With Conventional ProsthesesHiromu Kehara, Mohammed Kashem, Huaqing Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidinesTodd Bosanac, Eugene R Hickey, John Ginn, et al.
Innovations (Philadelphia, Pa.)|September 9, 2016
Ascending Aortic Endoballoon Occlusion Feasible Despite Moderately Enlarged Aorta to Facilitate Robotic Mitral Valve SurgerySarah L Breves, Inki Hong, James McCarthy, et al.
Annals of Thoracic Surgery Short Reports|June 10, 2026
Coronary Artery Bypass Grafting to Acute Marginal Branch: Forgotten Coronary ArterySamuel Ricci, Hiromu Kehara, Sean M Baskin, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2011
Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivityThomas M Kirrane, Stephen J Boyer, Jennifer Burke, et al.
Transplantation|December 16, 2022
Lung Transplantation for COVID-19 Pulmonary SequelaeHiromu Kehara, Chirantan Mangukia, Gengo Sunagawa, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2010
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 2, optimization for blood pressure reduction in spontaneously hypertensive ratsJohn D Ginn, Todd Bosanac, Rhonda Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2011
Indole RSK inhibitors. Part 1: discovery and initial SARStephen J Boyer, Jennifer Burke, Xin Guo, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK)Charles L Cywin, Bao-Ping Zhao, Daniel W McNeil, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Science of the Total Environment|February 25, 2023
Microalgal bioremediation of brackish aquaculture wastewaterAbdurahman Hafez Mohammed Kashem, Probir Das, Mohammad AbdulQuadir, et al.
Annals of Thoracic Surgery Short Reports|March 18, 2025
The Ross Procedure in Active Infective Endocarditis: A Comparison With Conventional ProsthesesHiromu Kehara, Mohammed Kashem, Huaqing Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidinesTodd Bosanac, Eugene R Hickey, John Ginn, et al.
Innovations (Philadelphia, Pa.)|September 9, 2016
Ascending Aortic Endoballoon Occlusion Feasible Despite Moderately Enlarged Aorta to Facilitate Robotic Mitral Valve SurgerySarah L Breves, Inki Hong, James McCarthy, et al.
Annals of Thoracic Surgery Short Reports|June 10, 2026
Coronary Artery Bypass Grafting to Acute Marginal Branch: Forgotten Coronary ArterySamuel Ricci, Hiromu Kehara, Sean M Baskin, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2011
Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivityThomas M Kirrane, Stephen J Boyer, Jennifer Burke, et al.
Transplantation|December 16, 2022
Lung Transplantation for COVID-19 Pulmonary SequelaeHiromu Kehara, Chirantan Mangukia, Gengo Sunagawa, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2010
Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 2, optimization for blood pressure reduction in spontaneously hypertensive ratsJohn D Ginn, Todd Bosanac, Rhonda Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2011
Indole RSK inhibitors. Part 1: discovery and initial SARStephen J Boyer, Jennifer Burke, Xin Guo, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK)Charles L Cywin, Bao-Ping Zhao, Daniel W McNeil, et al.
Pageof 3